TheProfitWatch

KYTX - Kyverna Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
7.05 0.1 (1.42%) --- --- --- -0.28 (-3.97%) 0.4 (5.87%) -0.08 (-1.11%) -0.08 (-1.11%)

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.97
Diluted EPS:
-0.97
Basic P/E:
-7.3711
Diluted P/E:
-7.3711
RSI(14) 1m:
0.0
VWAP:
7.15
RVol:
0.9064

Events

Period Kind Movement Occurred At
1m Price decrease 1m 7.37 -0.08 (-1.07%) Oct 15 14:49
1m Price decrease 1m 7.44 -0.1 (-1.34%) Oct 15 14:35
1m Price increase 1m 7.59 +0.09 (+1.2%) Oct 15 14:34
1m Price increase 1m 7.55 +0.08 (+1.07%) Oct 15 14:25
1m Price increase 1m 7.41 +0.2 (+2.77%) Oct 15 14:18

Related News